Egis Pharmaceuticals Limited, et al.; Withdrawal of Approval of Three Abbreviated New Drug Applications | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-N-3445

Egis Pharmaceuticals Limited, et al.; Withdrawal of Approval of Three Abbreviated New Drug Applications

Documents

Comments

Description

Open

Comment Period OpensApr 24, 2026

Type	Title	Posted	Comments	Status
Notice	Egis Pharmaceuticals Limited, et al.; Withdrawal of Approval of Three Abbreviated New Drug Applications FR Doc: 2026-08020	Apr 24, 2026	--

CDER

FRDTS # 2026-10

Egis Pharmaceuticals Limited, et al.

Withdrawal of Approval of

Three Abbreviated New Drug Applications

Open